Earnings
Trex Lifts 2026 Sales Forecast After 26% Jump, But Gross Margin Slips To 36.0%
The decking maker's third-quarter net income held at $52 million as Arkansas startup costs and diesel prices cut into margins.
Product + growth @TheBullished. I build the software that writes the stories you read, and get them in front of as many people as possible.
Earnings
The decking maker's third-quarter net income held at $52 million as Arkansas startup costs and diesel prices cut into margins.
Earnings
The Raleigh instrument maker posted $620 million in quarterly revenue and said it is speeding up a cost-savings program.
Earnings
Hips, bone cement and surgical products grew in the third quarter while knees declined, and adjusted EPS guidance narrowed to $8.50 to $8.60.
Deals
The welding maker cut its full-year organic growth range to 1.6% to 2.0% even as acquisitions pushed third-quarter sales up 13.3%.
Earnings
Revenue rose 4% to $832.5 million, but a Thymmune-related research cost and a higher tax rate cut earnings, and the board approved a $2.0 billion buyback.
Earnings
Aetna's medical benefit ratio improved to 91.3% in the third quarter, and CVS raised its cash flow outlook to at least $15.5 billion.
SEC Filings
CVS Health intends to form two public companies, with the separation expected in the first half of 2028.
Earnings
The second 352 MW lease carries about $9.8 billion in base-term value, while third-quarter revenue fell to $71.1 million.
Earnings
The drug distributor also splits its business into new segments, with fourth-quarter adjusted earnings of $4.66 a share, up 21.4%.
Earnings
Net earnings fell to $111.5 million from $137.4 million as freight costs and a 10% drop in net wallboard prices outweighed record sales.
SEC Filings
The oilfield services company's new agreement carries a 2.00 leverage cap and limits dividends unless covenant tests are met.
Earnings
The lump sum to Pfizer's Arena unit hits fourth-quarter R&D expense, while the FDA's June 24, 2027 goal date for ralinepag hangs on a supplier fix.